In vivo imaging of neuroinflammation in schizophrenia

Schizophrenia Research

Volumn 173, Issue 3, 2016, Pages 200-212

  Pasternak, Ofer ^a,b   Kubicki, Marek ^a,c   Shenton, Martha E ^a,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b TEL AVIV UNIVERSITY   (Israel)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diffusion MRI; DTI; Free water; Magnetization transfer; MRI; Neuroimaging; Neuroinflammation; PET; Schizophrenia

Indexed keywords

CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; GLIA; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SCHIZOPHRENIA; WATER CONTENT; ANIMAL; BRAIN; DIAGNOSTIC IMAGING; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; BRAIN; HUMANS; INFLAMMATION; NEUROIMAGING; SCHIZOPHRENIA;

EID: 84930338510     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2015.05.034     Document Type: Review

References (177)

1. Agosta F., Pievani M., Sala S., Geroldi C., Galluzzi S., Frisoni G.B., Filippi M. White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011, 258(3):853-863.
2. Alexander A.L., Lee J.E., Lazar M., Field A.S. Diffusion tensor imaging of the brain. Neurother.: J. Am. Soc. Exp. Neurother. 2007, 4(3):316-329.
3. Allaman I., Belanger M., Magistretti P.J. Astrocyte-neuron metabolic relationships: for better and for worse. Trends Neurosci. 2011, 34(2):76-87.
4. Amaral A.I., Meisingset T.W., Kotter M.R., Sonnewald U. Metabolic aspects of neuron-oligodendrocyte-astrocyte interactions. Front. Endocrinol. 2013, 4:54.
5. Anderson G., Maes M. Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:5-19.
6. Andersson P.B., Perry V.H., Gordon S. The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 1992, 48(1):169-186.
7. Andreasen N.C., Ehrhardt J.C., Swayze V.W., Tyrrell G., Cohen G., Ku J.S., Arndt S. T1 and T2 relaxation times in schizophrenia as measured with magnetic resonance imaging. Schizophr. Res. 1991, 5(3):223-232.
8. Assaf Y., Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J. Mol. Neurosci. MN 2008, 34(1):51-61.
9. Avram A.V., Ozarslan E., Sarlls J.E., Basser P.J. In vivo detection of microscopic anisotropy using quadruple pulsed-field gradient (qPFG) diffusion MRI on a clinical scanner. NeuroImage 2013, 64:229-239.
10. Barnes D., McDonald W.I., Johnson G., Tofts P.S., Landon D.N. Quantitative nuclear magnetic resonance imaging: characterisation of experimental cerebral oedema. J. Neurol. Neurosurg. Psychiatry 1987, 50(2):125-133.
11. Bartels A.L., Willemsen A.T., Doorduin J., de Vries E.F., Dierckx R.A., Leenders K.L. [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?. Parkinsonism Relat. Disord. 2010, 16(1):57-59.
12. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys. J. 1994, 66(1):259-267.
13. Berger M., Gould M.K., Barnett P.G. The cost of positron emission tomography in six United States Veterans Affairs hospitals and two academic medical centers. AJR Am. J. Roentgenol. 2003, 181(2):359-365.
14. Bigler E.D. Neuroinflammation and the dynamic lesion in traumatic brain injury. Brain: J. Neurol. 2013, 136(Pt 1):9-11.
15. Bitsch A., Bruhn H., Vougioukas V., Stringaris A., Lassmann H., Frahm J., Bruck W. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am. J. Neuroradiol. 1999, 20(9):1619-1627.
16. Bleuler E. Dementia Praecox; or, The Group of Schizophrenias 1950, International Universities Press.
17. Bouix S., Pasternak O., Rathi Y., Pelavin P.E., Zafonte R., Shenton M.E. Increased gray matter diffusion anisotropy in patients with persistent post-concussive symptoms following mild traumatic brain injury. PLoS ONE 2013, 8(6). e66205.
18. Brand A., Richter-Landsberg C., Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci. 1993, 15(3-5):289-298.
19. Bruck W., Bitsch A., Kolenda H., Bruck Y., Stiefel M., Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann. Neurol. 1997, 42(5):783-793.
20. Budde M.D., Janes L., Gold E., Turtzo L.C., Frank J.A. The contribution of gliosis to diffusion tensor anisotropy and tractography following traumatic brain injury: validation in the rat using Fourier analysis of stained tissue sections. Brain: J. Neurol. 2011, 134(Pt 8):2248-2260.
21. Castillo M., Mukherji S.K. Clinical applications of FLAIR, HASTE, and magnetization transfer in neuroimaging. Semin. Ultrasound CT MR 2000, 21(6):417-427.
22. Cercignani M., Symms M.R., Schmierer K., Boulby P.A., Tozer D.J., Ron M., Tofts P.S., Barker G.J. Three-dimensional quantitative magnetisation transfer imaging of the human brain. NeuroImage 2005, 27(2):436-441.
23. Chang L., Munsaka S.M., Kraft-Terry S., Ernst T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J. Neuroimmune Pharmacol.: Off. J. Soc. Neuroimmune Pharmacol. 2013, 8(3):576-593.
24. Chauveau F., Boutin H., Van Camp N., Dolle F., Tavitian B. Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur. J. Nucl. Med. Mol. Imaging 2008, 35(12):2304-2319.
25. Chew L.J., Fusar-Poli P., Schmitz T. Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev. Neurosci. 2013, 35(2-3):102-129.
26. Christensen J., Holcomb J., Garver D.L. State-related changes in cerebral white matter may underlie psychosis exacerbation. Psychiatry Res. 2004, 130(1):71-78.
27. Claudio L., Kress Y., Factor J., Brosnan C.F. Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells. Am. J. Pathol. 1990, 137(5):1033-1045.
28. Claussen C., Laniado M., Schorner W., Niendorf H.P., Weinmann H.J., Fiegler W., Felix R. Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases. AJNR Am. J. Neuroradiol. 1985, 6(5):669-674.
29. Corot C., Robert P., Idee J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 2006, 58(14):1471-1504.
30. Dauguet J., Peled S., Berezovskii V., Delzescaux T., Warfield S.K., Born R., Westin C.F. Comparison of fiber tracts derived from in-vivo DTI tractography with 3D histological neural tract tracer reconstruction on a macaque brain. NeuroImage 2007, 37(2):530-538.
31. Deddens L.H., Van Tilborg G.A., Mulder W.J., De Vries H.E., Dijkhuizen R.M. Imaging neuroinflammation after stroke: current status of cellular and molecular MRI strategies. Cerebrovasc. Dis. 2012, 33(4):392-402.
32. DeLisi L.E., King A.C., Targum S. Serum immunoglobulin concentrations in patients admitted to an acute psychiatric in-patient service. Br. J. Psychiatry: J. Ment. Sci. 1984, 145:661-665.
33. DeLisi L.E., Szulc K.U., Bertisch H., Majcher M., Brown K., Bappal A., Branch C.A., Ardekani B.A. Early detection of schizophrenia by diffusion weighted imaging. Psychiatry Res. 2006, 148(1):61-66.
34. Deng W. Neurobiology of injury to the developing brain. Nat. Rev. Neurol. 2010, 6(6):328-336.
35. Dickens A.M., Vainio S., Marjamaki P., Johansson J., Lehtiniemi P., Rokka J., Rinne J., Solin O., Haaparanta-Solin M., Jones P.A., Trigg W., Anthony D.C., Airas L. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18 F-GE-180. J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 2014, 55(3):466-472.
36. Dobos N., de Vries E.F., Kema I.P., Patas K., Prins M., Nijholt I.M., Dierckx R.A., Korf J., den Boer J.A., Luiten P.G., Eisel U.L. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J. Alzheimers Dis. 2012, 28(4):905-915.
37. Doorduin J., de Vries E.F., Willemsen A.T., de Groot J.C., Dierckx R.A., Klein H.C. Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 2009, 50(11):1801-1807.
38. Du F., Cooper A., Cohen B.M., Renshaw P.F., Ongur D. Water and metabolite transverse T2 relaxation time abnormalities in the white matter in schizophrenia. Schizophr. Res. 2012, 137(1-3):241-245.
39. Du F., Cooper A.J., Thida T., Shinn A.K., Cohen B.M., Ongur D. Myelin and axon abnormalities in schizophrenia measured with magnetic resonance imaging techniques. Biol. Psychiatry 2013, 74(6):451-457.
40. Dula A.N., Gochberg D.F., Valentine H.L., Valentine W.M., Does M.D. Multiexponential T2, magnetization transfer, and quantitative histology in white matter tracts of rat spinal cord. Magn. Reson. Med.: Off. J. Soc. Magn. Reson. Med. / Soc. Magn. Reson. Med. 2010, 63(4):902-909.
41. Espinosa-Oliva A.M., de Pablos R.M., Herrera A.J. Intracranial injection of LPS in rat as animal model of neuroinflammation. Methods Mol. Biol. 2013, 1041:295-305.
42. Feigenson K.A., Kusnecov A.W., Silverstein S.M. Inflammation and the two-hit hypothesis of schizophrenia. Neurosci. Biobehav. Rev. 2014, 38:72-93.
43. Filiou M.D., Arefin A.S., Moscato P., Graeber M.B. 'Neuroinflammation' differs categorically from inflammation: transcriptomes of Alzheimer's disease, Parkinson's disease, schizophrenia and inflammatory diseases compared. Neurogenetics 2014, 15(3):201-212.
44. Fineberg A.M., Ellman L.M. Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol. Psychiatry 2013, 73(10):951-966.
45. Fitzsimmons J., Kubicki M., Shenton M.E. Review of functional and anatomical brain connectivity findings in schizophrenia. Curr. Opin. Psychiatry 2013, 26(2):172-187.
46. Fontana A., Frei K., Bodmer S., Hofer E. Immune-mediated encephalitis: on the role of antigen-presenting cells in brain tissue. Immunol. Rev. 1987, 100:185-201.
47. Frodl T., Amico F. Is there an association between peripheral immune markers and structural/functional neuroimaging findings?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 48:295-303.
48. Ganguli R., Rabin B.S., Kelly R.H., Lyte M., Ragu U. Clinical and laboratory evidence of autoimmunity in acute schizophrenia. Ann. N. Y. Acad. Sci. 1987, 496:676-685.
49. Garver D.L., Tamas R.L., Holcomb J.A. Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 2003, 28(8):1515-1520.
50. Garver D.L., Holcomb J.A., Christensen J.D. Compromised myelin integrity during psychosis with repair during remission in drug-responding schizophrenia. Int. J. Neuropsychopharmacol. / Off. Sci. J. Coll. Int. Neuropsychopharmacologicum 2008, 11(1):49-61.
51. Gerhard A., Schwarz J., Myers R., Wise R., Banati R.B. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. NeuroImage 2005, 24(2):591-595.
52. Gerhard A., Pavese N., Hotton G., Turkheimer F., Es M., Hammers A., Eggert K., Oertel W., Banati R.B., Brooks D.J. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 2006, 21(2):404-412.
53. Gonzalez-Scarano F., Grossman R.I., Galetta S., Atlas S.W., Silberberg D.H. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging. Ann. Neurol. 1987, 21(3):300-306.
54. Grossman R.I., Gonzalez-Scarano F., Atlas S.W., Galetta S., Silberberg D.H. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986, 161(3):721-725.
55. Guo Q., Owen D.R., Rabiner E.A., Turkheimer F.E., Gunn R.N. Identifying improved TSPO PET imaging probes through biomathematics: the impact of multiple TSPO binding sites in vivo. NeuroImage 2012, 60(2):902-910.
56. Haacke E.M., Brown R.W., Thompson M.R., Venkatesan R. Magnetic Resonance Imaging: Physical Principles and Sequence Design 1999, Wiley.
57. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain: J. Neurol. 1999, 122(Pt 4):593-624.
58. Harrison N.A., Cooper E., Dowell N.G., Keramida G., Voon V., Critchley H.D., Cercignani M. Quantitative magnetization transfer imaging as a biomarker for effects of systemic inflammation on the brain. Biol. Psychiatry 2014, (Epub ahead of print).
59. Henkelman R.M., Stanisz G.J., Graham S.J. Magnetization transfer in MRI: a review. NMR Biomed. 2001, 14(2):57-64.
60. Hoy A.R., Koay C.G., Kecskemeti S.R., Alexander A.L. Optimization of a free water elimination two-compartment model for diffusion tensor imaging. NeuroImage 2014, 103C:323-333.
61. Husstedt H.W., Sickert M., Kostler H., Haubitz B., Becker H. Diagnostic value of the fast-FLAIR sequence in MR imaging of intracranial tumors. Eur. Radiol. 2000, 10(5):745-752.
62. Inglese M., Bester M. Diffusion imaging in multiple sclerosis: research and clinical implications. NMR Biomed. 2010, 23(7):865-872.
63. Jaaro-Peled H., Ayhan Y., Pletnikov M.V., Sawa A. Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models. Schizophr. Bull. 2010, 36(2):301-313.
64. Jacobs A.H., Tavitian B., consortium I.N. Noninvasive molecular imaging of neuroinflammation. J. Cereb. Blood Flow. Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2012, 32(7):1393-1415.
65. Jones D.K., Cercignani M. Twenty-five pitfalls in the analysis of diffusion MRI data. NMR Biomed. 2010, 23(7):803-820.
66. Jones D.K., Knosche T.R., Turner R. White matter integrity, fiber count, and other fallacies: the do's and don'ts of diffusion MRI. NeuroImage 2013, 73:239-254.
67. Kahn R.S., Sommer I.E. The neurobiology and treatment of first-episode schizophrenia. Mol. Psychiatry 2015, 20(1):84-97.
68. Kannan S., Balakrishnan B., Muzik O., Romero R., Chugani D. Positron emission tomography imaging of neuroinflammation. J. Child Neurol. 2009, 24(9):1190-1199.
69. Kantarci K., Knopman D.S., Dickson D.W., Parisi J.E., Whitwell J.L., Weigand S.D., Josephs K.A., Boeve B.F., Petersen R.C., Jack C.R. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology 2008, 248(1):210-220.
70. Kenk M., Selvanathan T., Rao N., Suridjan I., Rusjan P., Remington G., Meyer J.H., Wilson A.A., Houle S., Mizrahi R. Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr. Bull. 2015, 41(1):85-93.
71. Kirkpatrick B., Miller B.J. Inflammation and schizophrenia. Schizophr. Bull. 2013, 39(6):1174-1179.
72. Kraepelin E. Dementia Praecox and Paraphrenia 1971, R. E. Krieger Pub. Co.
73. Kropholler M.A., Boellaard R., Schuitemaker A., van Berckel B.N., Luurtsema G., Windhorst A.D., Lammertsma A.A. Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2005, 25(7):842-851.
74. Kubicki M., Park H., Westin C.F., Nestor P.G., Mulkern R.V., Maier S.E., Niznikiewicz M., Connor E.E., Levitt J.J., Frumin M., Kikinis R., Jolesz F.A., McCarley R.W., Shenton M.E. DTI and MTR abnormalities in schizophrenia: analysis of white matter integrity. NeuroImage 2005, 26(4):1109-1118.
75. Kubicki M., McCarley R., Westin C.F., Park H.J., Maier S., Kikinis R., Jolesz F.A., Shenton M.E. A review of diffusion tensor imaging studies in schizophrenia. J. Psychiatr. Res. 2007, 41(1-2):15-30.
76. Laule C., Vavasour I.M., Kolind S.H., Li D.K., Traboulsee T.L., Moore G.R., MacKay A.L. Magnetic resonance imaging of myelin. Neurother.: J. Am. Soc. Exp. Neurother. 2007, 4(3):460-484.
77. Lavisse S., Guillermier M., Herard A.S., Petit F., Delahaye M., Van Camp N., Ben Haim L., Lebon V., Remy P., Dolle F., Delzescaux T., Bonvento G., Hantraye P., Escartin C. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J. Neurosci. 2012, 32(32):10809-10818.
78. Levitt J.J., Bobrow L., Lucia D., Srinivasan P. A selective review of volumetric and morphometric imaging in schizophrenia. Curr. Top. Behav. Neurosci. 2010, 4:243-281.
79. Liraz-Zaltsman S., Alexandrovich A.G., Trembovler V., Fishbein I., Yaka R., Shohami E., Biegon A. Regional sensitivity to neuroinflammation: in vivo and in vitro studies. Synapse 2011, 65(7):634-642.
80. Lodygensky G.A., Kunz N., Perroud E., Somm E., Mlynarik V., Huppi P.S., Gruetter R., Sizonenko S.V. Definition and quantification of acute inflammatory white matter injury in the immature brain by MRI/MRS at high magnetic field. Pediatr. Res. 2014, 75(3):415-423.
81. Maeda J., Suhara T., Zhang M.R., Okauchi T., Yasuno F., Ikoma Y., Inaji M., Nagai Y., Takano A., Obayashi S., Suzuki K. Novel peripheral benzodiazepine receptor ligand [11C]DAA1106 for PET: an imaging tool for glial cells in the brain. Synapse 2004, 52(4):283-291.
82. Makris N., Seidman L.J., Ahern T., Kennedy D.N., Caviness V.S., Tsuang M.T., Goldstein J.M. White matter volume abnormalities and associations with symptomatology in schizophrenia. Psychiatry Res. 2010, 183(1):21-29.
83. Mandl R.C., Schnack H.G., Luigjes J., van den Heuvel M.P., Cahn W., Kahn R.S., Hulshoff Pol H.E. Tract-based analysis of magnetization transfer ratio and diffusion tensor imaging of the frontal and frontotemporal connections in schizophrenia. Schizophr. Bull. 2010, 36(4):778-787.
84. Mandl R.C., Pasternak O., Cahn W., Kubicki M., Kahn R.S., Shenton M.E., Hulshoff Pol H.E. Comparing free water imaging and magnetization transfer measurements in schizophrenia. Schizophr. Res. 2015, 161(1):126-132.
85. Mansfield P., Morris P.G. NMR Imaging in Biomedicine 1982, Academic Press, New York.
86. Meyer U. Developmental neuroinflammation and schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:20-34.
87. Meyer C.R., Moffat B.A., Kuszpit K.K., Bland P.L., McKeever P.E., Johnson T.D., Chenevert T.L., Rehemtulla A., Ross B.D. A methodology for registration of a histological slide and in vivo MRI volume based on optimizing mutual information. Mol. Imaging 2006, 5(1):16-23.
88. Mezer A., Yeatman J.D., Stikov N., Kay K.N., Cho N.J., Dougherty R.F., Perry M.L., Parvizi J., Hua le H., Butts-Pauly K., Wandell B.A. Quantifying the local tissue volume and composition in individual brains with magnetic resonance imaging. Nat. Med. 2013, 19(12):1667-1672.
89. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70(7):663-671.
90. Monji A., Kato T., Kanba S. Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin. Neurosci. 2009, 63(3):257-265.
91. Monji A., Kato T.A., Mizoguchi Y., Horikawa H., Seki Y., Kasai M., Yamauchi Y., Yamada S., Kanba S. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 42:115-121.
92. Montero-Menei C.N., Sindji L., Pouplard-Barthelaix A., Jehan F., Denechaud L., Darcy F. Lipopolysaccharide intracerebral administration induces minimal inflammatory reaction in rat brain. Brain Res. 1994, 653(1-2):101-111.
93. Morozov D., Bar L., Sochen N., Cohen Y. Modeling of the diffusion MR signal in calibrated model systems and nerves. NMR Biomed. 2013, 26(12):1787-1795.
94. Moshkin M.P., Akulov A.E., Petrovskii D.V., Saik O.V., Petrovskii E.D., Savelov A.A., Koptug I.V. Magnetic resonance spectroscopy of metabolic changes in mice brain after 2-deoxy-D-glucose injection. Ross. Fiziol. Zh. Im. I M Sechenova 2012, 98(10):1264-1272.
95. Mossahebi P., Alexander A.L., Field A.S., Samsonov A.A. Removal of cerebrospinal fluid partial volume effects in quantitative magnetization transfer imaging using a three-pool model with nonexchanging water component. Magn. Reson. Med.: Off. J. Soc. Magn. Reson. Med. / Soc. Magn. Reson. Med. 2014, (Epub ahead of print).
96. Muehllehner G., Karp J.S. Positron emission tomography. Phys. Med. Biol. 2006, 51(13):R117-R137.
97. Muller N., Ulmschneider M., Scheppach C., Schwarz M.J., Ackenheil M., Moller H.J., Gruber R., Riedel M. COX-2 inhibition as a treatment approach in schizophrenia: immunological considerations and clinical effects of celecoxib add-on therapy. Eur. Arch. Psychiatry Clin. Neurosci. 2004, 254(1):14-22.
98. Najjar S., Pearlman D.M. Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr. Res. 2015, 161(1):102-112.
99. Najjar S., Pearlman D.M., Alper K., Najjar A., Devinsky O. Neuroinflammation and psychiatric illness. J. Neuroinflammation 2013, 10:43.
100. Ng T.S., Lin A.P., Koerte I.K., Pasternak O., Liao H., Merugumala S., Bouix S., Shenton M.E. Neuroimaging in repetitive brain trauma. Alzheimers Res. Ther. 2014, 6(1):10.
101. Nilsson M., Latt J., van Westen D., Brockstedt S., Lasic S., Stahlberg F., Topgaard D. Noninvasive mapping of water diffusional exchange in the human brain using filter-exchange imaging. Magn. Reson. Med.: Off. J. Soc. Magn. Reson. Med. / Soc. Magn. Reson. Med. 2013, 69(6):1573-1581.
102. O'Donnell L.J., Pasternak O. Does diffusion MRI tell us anything about the white matter? An overview of methods and pitfalls. Schizophr. Res. 2015, 161(1):133-141.
103. Oguz K.K., Kurne A., Aksu A.O., Karabulut E., Serdaroglu A., Teber S., Haspolat S., Senbil N., Kurul S., Anlar B. Assessment of citrullinated myelin by 1H-MR spectroscopy in early-onset multiple sclerosis. AJNR Am. J. Neuroradiol. 2009, 30(4):716-721.
104. Ongur D., Prescot A.P., Jensen J.E., Rouse E.D., Cohen B.M., Renshaw P.F., Olson D.P. T2 relaxation time abnormalities in bipolar disorder and schizophrenia. Magn. Reson. Med.: Off. J. Soc. Magn. Reson. Med. / Soc. Magn. Reson. Med. 2010, 63(1):1-8.
105. Owen D.R., Gunn R.N., Rabiner E.A., Bennacef I., Fujita M., Kreisl W.C., Innis R.B., Pike V.W., Reynolds R., Matthews P.M., Parker C.A. Mixed-affinity binding in humans with 18-kDa translocator protein ligands. J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 2011, 52(1):24-32.
106. Oz G., Alger J.R., Barker P.B., Bartha R., Bizzi A., Boesch C., Bolan P.J., Brindle K.M., Cudalbu C., Dincer A., Dydak U., Emir U.E., Frahm J., Gonzalez R.G., Gruber S., Gruetter R., Gupta R.K., Heerschap A., Henning A., Hetherington H.P., Howe F.A., Huppi P.S., Hurd R.E., Kantarci K., Klomp D.W., Kreis R., Kruiskamp M.J., Leach M.O., Lin A.P., Luijten P.R., Marjanska M., Maudsley A.A., Meyerhoff D.J., Mountford C.E., Nelson S.J., Pamir M.N., Pan J.W., Peet A.C., Poptani H., Posse S., Pouwels P.J., Ratai E.M., Ross B.D., Scheenen T.W., Schuster C., Smith I.C., Soher B.J., Tkac I., Vigneron D.B., Kauppinen R.A., Group M.R.S.C. Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014, 270(3):658-679.
107. Pandey R.S., Gupta A.K., Chaturvedi U.C. Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol. Psychiatry 1981, 16(12):1123-1136.
108. Pasternak O., Sochen N., Gur Y., Intrator N., Assaf Y. Free water elimination and mapping from diffusion MRI. Magn. Reson. Med.: Off. J. Soc. Magn. Reson. Med. / Soc. Magn. Reson. Med. 2009, 62(3):717-730.
109. Pasternak O., Shenton M.E., Westin C.F. Estimation of extracellular volume from regularized multi-shell diffusion MRI. Medical image computing and computer-assisted intervention : MICCAI . . . International Conference on Medical Image Computing and Computer-Assisted Intervention 15(Pt 2) 2012, 305-312.
110. Pasternak O., Westin C.F., Bouix S., Seidman L.J., Goldstein J.M., Woo T.U., Petryshen T.L., Mesholam-Gately R.I., McCarley R.W., Kikinis R., Shenton M.E., Kubicki M. Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J. Neurosci. 2012, 32(48):17365-17372.
111. Pasternak O., Koerte I.K., Bouix S., Fredman E., Sasaki T., Mayinger M., Helmer K.G., Johnson A.M., Holmes J.D., Forwell L.A., Skopelja E.N., Shenton M.E., Echlin P.S. Hockey concussion education project, part 2. microstructural white matter alterations in acutely concussed ice hockey players: a longitudinal free-water MRI study. J. Neurosurg. 2014, 120(4):873-881.
112. Pasternak O., Westin C.F., Dahlben B., Bouix S., Kubicki M. The extent of diffusion MRI markers of neuroinflammation and white matter deterioration in chronic schizophrenia. Schizophr. Res. 2015, 161(1):113-118.
113. Pfefferbaum A., Sullivan E.V., Hedehus M., Moseley M., Lim K.O. Brain gray and white matter transverse relaxation time in schizophrenia. Psychiatry Res. 1999, 91(2):93-100.
114. Pierpaoli C., Jezzard P., Basser P.J., Barnett A., Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 1996, 201(3):637-648.
115. Politis M., Pavese N., Tai Y.F., Kiferle L., Mason S.L., Brooks D.J., Tabrizi S.J., Barker R.A., Piccini P. Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: a multimodal imaging study. Hum. Brain Mapp. 2011, 32(2):258-270.
116. Port J.D., Agarwal N. MR spectroscopy in schizophrenia. J. Magn. Reson. Imaging JMRI 2011, 34(6):1251-1261.
117. Posse S., Otazo R., Dager S.R., Alger J. MR spectroscopic imaging: principles and recent advances. J. Magn. Reson. Imaging JMRI 2013, 37(6):1301-1325.
118. Price W.S. Pulsed-field gradient nuclear magnetic resonance as a tool for studying translational diffusion: part 1. Basic theory. Concepts Magn. Reson. 1997, 9(5):299-336.
119. Pulli B., Chen J.W. Imaging neuroinflammation - from bench to bedside. J. Clin. Cell Immunol. 2014, 5.
120. Ramadan S., Andronesi O.C., Stanwell P., Lin A.P., Sorensen A.G., Mountford C.E. Use of in vivo two-dimensional MR spectroscopy to compare the biochemistry of the human brain to that of glioblastoma. Radiology 2011, 259(2):540-549.
121. Ramlackhansingh A.F., Brooks D.J., Greenwood R.J., Bose S.K., Turkheimer F.E., Kinnunen K.M., Gentleman S., Heckemann R.A., Gunanayagam K., Gelosa G., Sharp D.J. Inflammation after trauma: microglial activation and traumatic brain injury. Ann. Neurol. 2011, 70(3):374-383.
122. Rausch M., Hiestand P., Baumann D., Cannet C., Rudin M. MRI-based monitoring of inflammation and tissue damage in acute and chronic relapsing EAE. Magn. Reson. Med.: Off. J. Soc. Magn. Reson. Med. / Soc. Magn. Reson. Med. 2003, 50(2):309-314.
123. Rigotti D.J., Inglese M., Gonen O. Whole-brain N-acetylaspartate as a surrogate marker of neuronal damage in diffuse neurologic disorders. AJNR Am. J. Neuroradiol. 2007, 28(10):1843-1849.
124. Rock R.B., Gekker G., Hu S., Sheng W.S., Cheeran M., Lokensgard J.R., Peterson P.K. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 2004, 17(4):942-964. table of contents.
125. Ropele S., Langkammer C., Enzinger C., Fuchs S., Fazekas F. Relaxation time mapping in multiple sclerosis. Expert. Rev. Neurother. 2011, 11(3):441-450.
126. Rupprecht R., Papadopoulos V., Rammes G., Baghai T.C., Fan J., Akula N., Groyer G., Adams D., Schumacher M. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat. Rev. Drug Discov. 2010, 9(12):971-988.
127. Schedlowski M., Engler H., Grigoleit J.S. Endotoxin-induced experimental systemic inflammation in humans: a model to disentangle immune-to-brain communication. Brain Behav. Immun. 2014, 35:1-8.
128. Schultzberg M., Lindberg C., Aronsson A.F., Hjorth E., Spulber S.D., Oprica M. Inflammation in the nervous system-physiological and pathophysiological aspects. Physiol. Behav. 2007, 92(1 - 2):121-128.
129. Schwartz M. Macrophages and microglia in central nervous system injury: are they helpful or harmful?. J. Cereb. Blood Flow Metab.: Off. J. Int. Soc. Cereb. Blood Flow Metab. 2003, 23(4):385-394.
130. Schwartz M., Butovsky O., Bruck W., Hanisch U.K. Microglial phenotype: is the commitment reversible?. Trends Neurosci. 2006, 29(2):68-74.
131. Schwerk A., Alves F.D., Pouwels P.J., van Amelsvoort T. Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies. J. Neurochem. 2014, 128(1):1-87.
132. Seppi K., Poewe W. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin. N. Am. 2010, 20(1):29-55.
133. Seyfer P., Pagenstecher A., Mandic R., Klose K.J., Heverhagen J.T. Cancer and inflammation: differentiation by USPIO-enhanced MR imaging. J. Magn. Reson. Imaging JMRI 2014, 39(3):665-672.
134. Shemesh N., Ozarslan E., Komlosh M.E., Basser P.J., Cohen Y. From single-pulsed field gradient to double-pulsed field gradient MR: gleaning new microstructural information and developing new forms of contrast in MRI. NMR Biomed. 2010, 23(7):757-780.
135. Shenton M.E., Dickey C.C., Frumin M., McCarley R.W. A review of MRI findings in schizophrenia. Schizophr. Res. 2001, 49(1 - 2):1-52.
136. Shenton M.E., Hamoda H.M., Schneiderman J.S., Bouix S., Pasternak O., Rathi Y., Vu M.A., Purohit M.P., Helmer K., Koerte I., Lin A.P., Westin C.F., Kikinis R., Kubicki M., Stern R.A., Zafonte R. A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury. Brain Imaging Behav. 2012, 6(2):137-192.
137. Sommer I.E., de Witte L., Begemann M., Kahn R.S. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. J. Clin. Psychiatry 2012, 73(4):414-419.
138. Sommer I.E., van Westrhenen R., Begemann M.J., de Witte L.D., Leucht S., Kahn R.S. Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update. Schizophr. Bull. 2014, 40(1):181-191.
139. Stamatovic S.M., Keep R.F., Andjelkovic A.V. Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. Curr. Neuropharmacol. 2008, 6(3):179-192.
140. Stanley J.A., Pettegrew J.W., Keshavan M.S. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part I. Biol. Psychiatry 2000, 48(5):357-368.
141. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., Bernstein H.G., Bogerts B. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 2008, 42(2):151-157.
142. Stejskal E.O., Tanner J.E. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J. Chem. Phys. 1965, 42(1):288-292.
143. Streit W.J. Microglial senescence: does the brain's immune system have an expiration date?. Trends Neurosci. 2006, 29(9):506-510.
144. Streit W.J., Graeber M.B., Kreutzberg G.W. Functional plasticity of microglia: a review. Glia 1988, 1(5):301-307.
145. Streit W.J., Mrak R.E., Griffin W.S. Microglia and neuroinflammation: a pathological perspective. J. Neuroinflammation 2004, 1(1):14.
146. Streit W.J., Xue Q.S., Tischer J., Bechmann I. Microglial pathology. Acta Neuropathol. Commun. 2014, 2:142.
147. Supprian T., Hofmann E., Warmuth-Metz M., Franzek E., Becker T. MRI T2 relaxation times of brain regions in schizophrenic patients and control subjects. Psychiatry Res. 1997, 75(3):173-182.
148. Sykova E., Nicholson C. Diffusion in brain extracellular space. Physiol. Rev. 2008, 88(4):1277-1340.
149. Szafer A., Zhong J., Anderson A.W., Gore J.C. Diffusion-weighted imaging in tissues: theoretical models. NMR Biomed. 1995, 8(7-8):289-296.
150. Szymanski S., Ashtari M., Zito J., Degreef G., Bogerts B., Lieberman J. Gadolinium-DTPA enhanced gradient echo magnetic resonance scans in first episode of psychosis and chronic schizophrenic patients. Psychiatry Res. 1991, 40(3):203-207.
151. Takano A., Arakawa R., Ito H., Tateno A., Takahashi H., Matsumoto R., Okubo Y., Suhara T. Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. Int. J. Neuropsychopharmacol. / Off. Sci. J. Coll. Int. Neuropsychopharmacologicum 2010, 13(7):943-950.
152. Taschner C.A., Wetzel S.G., Tolnay M., Froehlich J., Merlo A., Radue E.W. Characteristics of ultrasmall superparamagnetic iron oxides in patients with brain tumors. AJR Am. J. Roentgenol. 2005, 185(6):1477-1486.
153. Thiel A., Radlinska B.A., Paquette C., Sidel M., Soucy J.P., Schirrmacher R., Minuk J. The temporal dynamics of poststroke neuroinflammation: a longitudinal diffusion tensor imaging-guided PET study with 11C-PK11195 in acute subcortical stroke. J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 2010, 51(9):1404-1412.
154. Tilleux S., Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J. Neurosci. Res. 2007, 85(10):2059-2070.
155. Torrey E.F., Peterson M.R. Slow and latent viruses in schizophrenia. Lancet 1973, 2(7819):22-24.
156. Tourdias T., Dousset V. Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy. Neurother.: J. Am. Soc. Exp. Neurother. 2013, 10(1):111-123.
157. Turkheimer F.E., Edison P., Pavese N., Roncaroli F., Anderson A.N., Hammers A., Gerhard A., Hinz R., Tai Y.F., Brooks D.J. Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J. Nucl. Med.: Off. Publ. Soc. Nucl. Med. 2007, 48(1):158-167.
158. van Berckel B.N., Bossong M.G., Boellaard R., Kloet R., Schuitemaker A., Caspers E., Luurtsema G., Windhorst A.D., Cahn W., Lammertsma A.A., Kahn R.S. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 2008, 64(9):820-822.
159. van de Looij Y., Lodygensky G.A., Dean J., Lazeyras F., Hagberg H., Kjellmer I., Mallard C., Huppi P.S., Sizonenko S.V. High-field diffusion tensor imaging characterization of cerebral white matter injury in lipopolysaccharide-exposed fetal sheep. Pediatr. Res. 2012, 72(3):285-292.
160. Vartanian M.E., Kolyaskina G.I., Lozovsky D.V., Burbaeva G.S., Ignatov S.A. Aspects of humoral and cellular immunity in schizophrenia. Birth Defects Orig. Artic. Ser. 1978, 14(5):339-364.
161. Vavasour I.M., Laule C., Li D.K., Traboulsee A.L., MacKay A.L. Is the magnetization transfer ratio a marker for myelin in multiple sclerosis?. J. Magn. Reson. Imaging JMRI 2011, 33(3):713-718.
162. Vellinga M.M., Oude Engberink R.D., Seewann A., Pouwels P.J., Wattjes M.P., van der Pol S.M., Pering C., Polman C.H., de Vries H.E., Geurts J.J., Barkhof F. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Brain: J. Neurol. 2008, 131(Pt 3):800-807.
163. Venneti S., Lopresti B.J., Wiley C.A. Molecular imaging of microglia/macrophages in the brain. Glia 2013, 61(1):10-23.
164. Versijpt J., Debruyne J.C., Van Laere K.J., De Vos F., Keppens J., Strijckmans K., Achten E., Slegers G., Dierckx R.A., Korf J., De Reuck J.L. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult. Scler. 2005, 11(2):127-134.
165. Vogel M., Meier J., Gronke S., Waage M., Schneider W., Freyberger H.J., Klauer T. Differential effects of childhood abuse and neglect: mediation by posttraumatic distress in neurotic disorder and negative symptoms in schizophrenia?. Psychiatry Res. 2011, 189(1):121-127.
166. Wang Y., Wang Q., Haldar J.P., Yeh F.C., Xie M., Sun P., Tu T.W., Trinkaus K., Klein R.S., Cross A.H., Song S.K. Quantification of increased cellularity during inflammatory demyelination. Brain: J. Neurol. 2011, 134(Pt 12):3590-3601.
167. Weiner H.L., Selkoe D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature 2002, 420(6917):879-884.
168. Westin C.F., Szczepankiewicz F., Pasternak O., Ozarslan E., Topgaard D., Knutsson H., Nilsson M. Measurement tensors in diffusion MRI: generalizing the concept of diffusion encoding. Med. Image Comput. Comput.-Assist. Interv.: Miccai Int. Conf. Med. Image Comput. Comput.-Assist. Interv. 2014, 17(Pt 3):209-216.
169. White T., Schmidt M., Karatekin C. White matter 'potholes' in early-onset schizophrenia: a new approach to evaluate white matter microstructure using diffusion tensor imaging. Psychiatry Res. 2009, 174(2):110-115.
170. White T., Ehrlich S., Ho B.C., Manoach D.S., Caprihan A., Schulz S.C., Andreasen N.C., Gollub R.L., Calhoun V.D., Magnotta V.A. Spatial characteristics of white matter abnormalities in schizophrenia. Schizophr. Bull. 2013, 39(5):1077-1086.
171. Williamson P., Pelz D., Merskey H., Morrison S., Karlik S., Drost D., Carr T., Conlon P. Frontal, temporal, and striatal proton relaxation times in schizophrenic patients and normal comparison subjects. Am. J. Psychiatry 1992, 149(4):549-551.
172. Yarnykh V.L. Pulsed Z-spectroscopic imaging of cross-relaxation parameters in tissues for human MRI: theory and clinical applications. Magn. Reson. Med.: Off. J. Soc. Magn. Reson. Med. / Soc. Magn. Reson. Med. 2002, 47(5):929-939.
173. Yarnykh V.L., Yuan C. Cross-relaxation imaging reveals detailed anatomy of white matter fiber tracts in the human brain. NeuroImage 2004, 23(1):409-424.
174. Yeste A., Quintana F.J. Antigen microarrays for the study of autoimmune diseases. Clin. Chem. 2013, 59(7):1036-1044.
175. Zahr N.M., Mayer D., Rohlfing T., Sullivan E.V., Pfefferbaum A. Imaging neuroinflammation? A perspective from MR spectroscopy. Brain Pathol. 2014, 24(6):654-664.
176. Zhang H., Schneider T., Wheeler-Kingshott C.A., Alexander D.C. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. NeuroImage 2012, 61(4):1000-1016.
177. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57(2):178-201.